Bruker Corporation to Present at Upcoming Investor Conferences

Rhea-AI Summary

Bruker (BRKR) has announced its participation in three upcoming investor conferences. Executive Vice President & CFO Gerald Herman will represent the company at the Stifel 2024 Healthcare Conference in New York on November 18, the Wolfe Research 2024 Healthcare Conference in New York on November 19, and the Nasdaq 51st Investor Conference in London on December 10, 2024.

Live audiovisual webcasts will be available on Bruker's Investor Relations website, with replays accessible for 90 days after the events.

BILLERICA, Mass.--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences:

Stifel 2024 Healthcare Conference in New York City
Monday, November 18, 2024, at 8:35 a.m. Eastern Time

Wolfe Research 2024 Healthcare Conference in New York City
Tuesday, November 19, 2024, at 4:10 p.m. Eastern Time

Nasdaq 51^st Investor Conference in London, UK
Tuesday, December 10, 2024, at 6:30 a.m. Eastern Time

Live audiovisual webcasts of the presentations will be available on the Investor Relations section of the Company's website at https://ir.bruker.com. Replays of the presentations will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the events and will be available for 90 days following the presentations.

About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241112686671/en/

Joe Kostka

Director, Investor Relations

Bruker Corporation

T: +1 (978) 313-5800

E: Investor.Relations@bruker.com

Source: Bruker Corporation

FAQ

When is Bruker (BRKR) presenting at the Stifel 2024 Healthcare Conference?

Bruker (BRKR) will present at the Stifel 2024 Healthcare Conference on Monday, November 18, 2024, at 8:35 a.m. Eastern Time in New York City.

Which conferences will Bruker (BRKR) attend in November and December 2024?

Bruker will attend three conferences: Stifel Healthcare Conference (Nov 18), Wolfe Research Healthcare Conference (Nov 19) in New York, and Nasdaq 51st Investor Conference (Dec 10) in London.

How long will Bruker's (BRKR) conference presentation replays be available?

Replays of Bruker's conference presentations will be available for 90 days following each event on the company's Investor Relations website.

Who will represent Bruker (BRKR) at the 2024 investor conferences?

Gerald Herman, Executive Vice President & CFO, will represent Bruker at the investor conferences.